ILiAD Biotechnologies
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pertussis Challenge Study in Adults Vaccinated With BPZE1 (NCT05461131) | ILiAD Biotechnologies | 2022-06-20 |
| Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children (NCT05116241) | ILiAD Biotechnologies | 2021-11-11 |
| Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults (NCT03942406) | ILiAD Biotechnologies | 2019-06-15 |
Track ILiAD Biotechnologies automatically
Every clearance here is in the API, with alerts when new ones post.